Of four treatment response measures recorded at 6 months of mepolizumab treatment, an Asthma Control Questionnaire score was ...

Nucala injection is prescribed for eosinophilic asthma and certain other conditions. It’s important to administer the injection safely and correctly so that the medication will be effective.

Depemokimab is a follow-up to GSK's Nucala (mepolizumab), a once-monthly IL-5 inhibitor approved for severe asthma, CRSwNP, ...

Image Source: Zacks Investment Research Nucala is already approved in several countries for treating eosinophil-driven diseases like severe eosinophilic asthma and eosinophilic granulomatosis with ...

The China National Medical Products Administration (NMPA) has approved GSK’s Nucala (mepolizumab ... Previously approved in China for severe eosinophilic asthma in adult and adolescent ...

A set of chameleon-like immune cells could be contributing to severe asthma in some patients.Intermediate group 2 i ...

Recent studies have highlighted the role of type 2 inflammation in EOM, which is similar to the inflammatory processes seen in asthma and eosinophilic rhinosinusitis. This has led to a ...

GSK's Nucala approved in China for CRSwNP ... for adults and adolescents aged 12 years and older with severe eosinophilic asthma as well as for adults with eosinophilic granulomatosis with ...

GSK (GSK) announced that the China National Medical Products Administration has approved Nucala, a monoclonal ... aged 12 years and older with severe eosinophilic asthma as well as for adults ...

Targeted biologic drugs have revolutionized the treatment of severe asthma driven by eosinophils, which are white blood cells linked to ILC2s, researchers noted in a recent study in the journal ...